Latest Insider Transactions at Teladoc Health, Inc. (TDOC)
This section provides a real-time view of insider transactions for Teladoc Health, Inc. (TDOC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Teladoc Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Teladoc Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2024
|
Jason Eric Evans Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,016
+16.66%
|
-
|
|
Dec 03
2024
|
Carlos Nueno President, International |
SELL
Open market or private sale
|
Direct |
2,890
-100.0%
|
$31,790
$11.23 P/Share
|
|
Dec 03
2024
|
Fernando M. Rodrigues President of BetterHelp |
SELL
Open market or private sale
|
Direct |
14,091
-100.0%
|
$155,001
$11.07 P/Share
|
|
Dec 02
2024
|
Carlos Nueno President, International |
SELL
Open market or private sale
|
Direct |
2,389
-45.25%
|
$26,279
$11.93 P/Share
|
|
Dec 02
2024
|
Fernando M. Rodrigues President of BetterHelp |
SELL
Open market or private sale
|
Direct |
7,873
-35.85%
|
$86,603
$11.93 P/Share
|
|
Dec 02
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,783
-8.65%
|
$96,613
$11.93 P/Share
|
|
Dec 02
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
4,004
-7.41%
|
$44,044
$11.93 P/Share
|
|
Dec 02
2024
|
Kelly Bliss President, U.S. Group Health |
SELL
Open market or private sale
|
Direct |
2,040
-5.95%
|
$22,440
$11.93 P/Share
|
|
Nov 29
2024
|
Carlos Nueno President, International |
BUY
Exercise of conversion of derivative security
|
Direct |
5,279
+40.34%
|
-
|
|
Nov 29
2024
|
Fernando M. Rodrigues President of BetterHelp |
BUY
Exercise of conversion of derivative security
|
Direct |
21,964
+50.0%
|
-
|
|
Nov 29
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,804
+3.92%
|
-
|
|
Nov 29
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
7,804
+4.75%
|
-
|
|
Nov 29
2024
|
Kelly Bliss President, U.S. Group Health |
BUY
Exercise of conversion of derivative security
|
Direct |
6,081
+5.83%
|
-
|
|
Oct 02
2024
|
Kelly Bliss President, U.S. Group Health |
SELL
Open market or private sale
|
Direct |
897
-3.08%
|
$7,176
$8.68 P/Share
|
|
Oct 01
2024
|
Kelly Bliss President, U.S. Group Health |
BUY
Exercise of conversion of derivative security
|
Direct |
2,631
+8.29%
|
-
|
|
Sep 20
2024
|
Jason Eric Evans Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,065
+50.0%
|
-
|
|
Sep 12
2024
|
Thomas Mckinley Director |
BUY
Open market or private purchase
|
Direct |
4,000
+9.29%
|
$28,000
$7.69 P/Share
|
|
Sep 04
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
468
-1.37%
|
$3,276
$7.26 P/Share
|
|
Sep 04
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
20,773
-50.0%
|
$145,411
$7.26 P/Share
|
|
Sep 03
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,114
-3.16%
|
$7,798
$7.16 P/Share
|
|
Sep 03
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,617
-3.75%
|
$11,319
$7.16 P/Share
|
|
Sep 03
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,218
-5.11%
|
$29,526
$7.16 P/Share
|
|
Sep 03
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,777
-5.35%
|
$12,439
$7.16 P/Share
|
|
Sep 03
2024
|
James L. Cave INTERIM CAO |
SELL
Open market or private sale
|
Direct |
555
-3.86%
|
$3,885
$7.16 P/Share
|
|
Sep 03
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
2,083
-4.09%
|
$14,581
$7.16 P/Share
|
|
Sep 03
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,817
-5.74%
|
$19,719
$7.16 P/Share
|
|
Sep 03
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,033
-1.35%
|
$7,231
$7.16 P/Share
|
|
Sep 03
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,750
-9.26%
|
$61,250
$7.16 P/Share
|
|
Sep 03
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
1,795
-3.84%
|
$12,565
$7.16 P/Share
|
|
Aug 30
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,117
+4.27%
|
-
|
|
Aug 30
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
5,504
+4.2%
|
-
|
|
Aug 30
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,313
+4.84%
|
-
|
|
Aug 30
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+4.87%
|
-
|
|
Aug 30
2024
|
James L. Cave INTERIM CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,884
+4.29%
|
-
|
|
Aug 30
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,768
+3.74%
|
-
|
|
Aug 30
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
7,803
+5.23%
|
-
|
|
Aug 30
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,855
+0.94%
|
-
|
|
Aug 30
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,804
+4.21%
|
-
|
|
Aug 30
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,023
+3.55%
|
-
|
|
Aug 15
2024
|
Mark Douglas Smith Director |
BUY
Open market or private purchase
|
Direct |
4,000
+32.38%
|
$28,000
$7.08 P/Share
|
|
Aug 12
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
206
-0.28%
|
$1,442
$7.13 P/Share
|
|
Aug 09
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
568
+0.76%
|
-
|
|
Aug 07
2024
|
Thomas Mckinley Director |
BUY
Open market or private purchase
|
Direct |
4,000
+10.24%
|
$28,000
$7.19 P/Share
|
|
Aug 07
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-24.93%
|
$105,000
$7.6 P/Share
|
|
Aug 06
2024
|
Thomas Mckinley Director |
BUY
Open market or private purchase
|
Direct |
7,000
+18.38%
|
$49,000
$7.57 P/Share
|
|
Aug 05
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,537
-4.57%
|
$10,759
$7.33 P/Share
|
|
Aug 02
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
6,053
-7.54%
|
$48,424
$8.14 P/Share
|
|
Aug 02
2024
|
Laizer Kornwasser Advisor to the CEO |
SELL
Open market or private sale
|
Direct |
10,879
-9.82%
|
$87,032
$8.14 P/Share
|
|
Aug 02
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,857
-10.28%
|
$30,856
$8.14 P/Share
|
|
Aug 01
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,319
+12.36%
|
-
|